COST-EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH NYHA I AND NYHA II HEART FAILURE IN SPAIN
نویسندگان
چکیده
منابع مشابه
Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain.
OBJECTIVES The aim of the study was to combine clinical results from the European Cohort of the REVERSE study and costs associated with the addition of cardiac resynchronization therapy (CRT) to optimal medical therapy (OMT) in patients with mild symptomatic (NYHA I-II) or asymptomatic left ventricular dysfunction and markers of cardiac dyssynchrony in Spain. METHODS A Markov model was develo...
متن کاملCost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
OBJECTIVES The aim of the study was to evaluate the cost-effectiveness (CE) of treatment with eplerenone versus standard care in adult patients with New York Heart Association class II chronic heart failure and reduced left ventricular ejection fraction from the perspective of the Greek national health care payer. METHODS A discrete-event model simulating the clinical course and respective ou...
متن کاملCost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure.
BACKGROUND Heart failure is a common, costly, and debilitating illness. Resynchronization of ventricular contraction in patients with heart failure improves ejection fraction. The long-term morbidity and costs associated with such cardiac resynchronization therapy remain unclear. OBJECTIVE To assess the incremental cost-effectiveness of cardiac resynchronization therapy. DESIGN Markov model...
متن کاملCRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
Patients with advanced heart failure (HF) have high mortality rates, to a relatively greater extent in those with New York Heart Association (NYHA) functional class IV versus III, justifying consideration of cardiac transplantation in this high-risk population.1,2 For many of these patients, gains in pharmacologic therapy have helped significantly in delaying progression to transplantation requ...
متن کاملSkeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients
BACKGROUND Heart failure (HF), a debilitating disease in a growing number of adults, exerts structural and neurohormonal changes in both cardiac and skeletal muscles. However, these alterations and their affected molecular pathways remain uncharacterized. Disease progression is known to transform skeletal muscle fiber composition by unknown mechanisms. In addition, perturbation of specific horm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Technology Assessment in Health Care
سال: 2013
ISSN: 0266-4623,1471-6348
DOI: 10.1017/s0266462313000123